The Discovery of the Factor Xa Inhibitor Otamixaban: From Lead Identification to Clinical Development

E-ISSN： 1875-533x|14|23|2471-2481

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.14, Iss.23, 2007-10, pp. : 2471-2481

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovery of the Factor Xa Inhibitor, ZK 807834 (CI-1031)

Current Topics in Medicinal Chemistry, Vol. 1, Iss. 2, 2001-06 ,pp. : 121-136

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Discovery and Development of Direct Coagulation Factor Xa Inhibitors

Current Pharmaceutical Design, Vol. 9, Iss. 28, 2003-11 ,pp. : 2337-2347

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the discovery of Factor Xa inhibitors

By Casimiro-Garcia Agustin Dudley Danette A Heemstra Ronald J Filipski Kevin J Bigge Christopher F Edmunds Jeremy J

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 2, 2006-02 ,pp. : 119-145

Informa Healthcare

Access to resources Recommend Favorite

Kinetic Characterization of Factor Xa Binding Using a Quenched Fluorescent Substrate Based on the Reactive Site of Factor Xa Inhibitor from Bauhinia ungulata Seeds

Current Medicinal Chemistry, Vol. 10, Iss. 13, 2003-07 ,pp. : 1085-1093

Bentham Science Publishers

Access to resources Recommend Favorite

Initial Structure-Activity Relationships for a Caprolactam-based Series of Neutral Factor Xa Inhibitors: Lead Identification

Letters in Drug Design & Discovery, Vol. 2, Iss. 8, 2005-12 ,pp. : 625-630

Bentham Science Publishers

Access to resources Recommend Favorite